The company said that on April 14, 2025 it signed a definitive agreement with S&P Global to sell its joint venture OSTTRA to funds managed by KKR. The total enterprise value is $3.1 billion, subject to customary purchase price adjustments.

8-KRegulation FD DisclosureFiled Apr 14, 2025Period of report Apr 14, 2025Summary published (UTC) Oct 17, 2026

Key points

AI summary

The company said that on April 14, 2025 it signed a definitive agreement with S&P Global to sell its joint venture OSTTRA to funds managed by KKR. The total enterprise value is $3.1 billion, subject to customary purchase price adjustments.
The company said the OSTTRA sale proceeds will be divided evenly between S&P Global and CME Group under their 50/50 joint venture structure. It cited no other specific financial terms as disclosed.
The company expects the transaction to close in the second half of 2025, subject to customary closing conditions and receipt of required regulatory approvals, it said.
The company said OSTTRA co-CEOs Guy Rowcliffe and John Stewart will continue to lead the business in their current roles. It also said KKR will support the creation of an equity ownership program for nearly 1,500 employees after the deal closes.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Agreement to Sell OSTTRA to KKR for $3.1 billion

The company said that on April 14, 2025 it signed a definitive agreement with S&P Global to sell its joint venture OSTTRA to funds managed by KKR. The total enterprise value is $3.1 billion, subject to customary purchase price adjustments.

Source · Based on the filing body and exhibits

CME Group and S&P Global 50/50 Split

The company said the OSTTRA sale proceeds will be divided evenly between S&P Global and CME Group under their 50/50 joint venture structure. It cited no other specific financial terms as disclosed.

Source · Based on the filing body and exhibits

Closing Timing and Conditions

The company expects the transaction to close in the second half of 2025, subject to customary closing conditions and receipt of required regulatory approvals, it said.

Source · Based on the filing body and exhibits

OSTTRA Management Continuity and Employee Equity Program

The company said OSTTRA co-CEOs Guy Rowcliffe and John Stewart will continue to lead the business in their current roles. It also said KKR will support the creation of an equity ownership program for nearly 1,500 employees after the deal closes.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.